IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer

Por Palmieri, Carlo, Szydlo, Richard, Miller, Marie, Barker, Laura, Patel, Neva H., Sasano, Hironobu, Barwick, Tara, Tam, Henry, Hadjiminas, Dimitri, Lee, Jasmin, Shaaban, Abeer, Nicholas, Hanna, Coombes, R. Charles, Kenny, Laura M.
Publicado no Breast Cancer Res Treat (2017)

IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients

Por Palmieri, Carlo, Stein, Rob C., Liu, Xinxue, Hudson, Emma, Nicholas, Hanna, Sasano, Hironobu, Guestini, Fouzia, Holcombe, Chris, Barrett, Sophie, Kenny, Laura, Reed, Sadie, Lim, Adrian, Hayward, Larry, Howell, Sacha, Coombes, R. Charles
Publicado no Breast Cancer Res Treat (2017)

Long term follow-up of the Intergroup Exemestane Study (IES)

Por Morden, James P, Alvarez, Isabel, Bertelli, Gianfilippo, Coates, Alan S, Coleman, Robert, Fallowfield, Lesley, Jassem, Jacek, Jones, Stephen, Kilburn, Lucy, Lønning, Per E., Ortmann, Olaf, Snowdon, Claire, van de Velde, Cornelis, Andersen, Jørn, Del Mastro, Lucia, Dodwell, David, Holmberg, Stig, Nicholas, Hanna, Paridaens, Robert, Bliss, Judith M, Coombes, R. Charles
Publicado no J Clin Oncol (2017)